paroxysmal nocturnal haemoglobinuria

paroxysmal nocturnal haemoglobinuria

A rare disease featuring episodic HAEMOLYSIS that occurs during the night when a decline in the pH of the blood triggers activation of complement components. The release of haemoglobin into the blood causes the morning urine to be black. The condition also features thrombosis and this may involve the hepatic vein causing the BUDD-CHIARI SYNDROME.
References in periodicals archive ?
The programme will first include eculizumab, a drug to treat paroxysmal nocturnal haemoglobinuria.
The product is claimed to be a highly innovative, longer-acting anti-C5 antibody that inhibits terminal complement, which is being evaluated to treat patients with paroxysmal nocturnal haemoglobinuria (PNH).
John Duggan, 33, was initially refused Soliris by HSE bosses to fight Paroxysmal Nocturnal Haemoglobinuria with which he was diagnosed in 2010.
The event at Banney Royd raised cash for treatment of Paroxysmal Nocturnal Haemoglobinuria (PNH) at St James's Hospital, Leeds.
2] Hypercoagulation disorders such as systemic lupus erythematosus, antiphospholipid syndrome, the presence of factor V Leiden, paroxysmal nocturnal haemoglobinuria, hyperhomocysteinaemia, protein C and S deficiency, and heparin-induced thrombocytopenia are also all reported as risk factors for ovarian vein thrombosis.
Flow cytometry may be considered to investigate for an abnormal clone in the case of paroxysmal nocturnal haemoglobinuria and may be used on bone marrow samples to further evaluate the cells.
Several cases of venous thromboembolism have now been documented: one case of ipsilateral forearm deep vein thrombosis following an infusion reaction [1]; one case of hepatic vein thrombosis in a patient found to have underlying paroxysmal nocturnal haemoglobinuria [2]; one case of retinal vein thrombosis [3] and one case of pulmonary embolism [4].
Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes.
According to the adopted CHMP opinion, Soliris (eculizumab) is indicated for the treatment of patients with paroxysmal nocturnal haemoglobinuria (PNH).
The company will use the funds to advance its immunotherapy programmes, such as paroxysmal nocturnal haemoglobinuria and geographic atrophy, an advanced form of dry type age-related macular degeneration, in addition to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
For 33-year-old John Duggan, who suffers from rare blood disorder Paroxysmal Nocturnal Haemoglobinuria, his life is priceless.

Full browser ?